161. Properties of a chimeric BoNT/A1-A4. (25th December 2016) Authors: Scheps, Daniel; Schmidt, Michael; Hofmann, Fred; Jurk, Marcel; López de la Paz, Manuela; Frevert, Jürgen Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S74 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
162. Pseudodystonic upper limb secondary to thalamic lesions: Usefulness of ultrasound-guided botulinum toxin treatment. (25th December 2016) Authors: Costa, Cristina; Lobo, Patrícia Pita Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S19 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
163. Purification and characterization of recombinant botulinum neurotoxin serotype FA, also known as serotype H. (25th December 2016) Authors: Hackett, Gavin; Moore, Kevin; Burgin, David; Hornby, Fraser; Gray, Bryony; Elliott, Mark; Beard, Matthew Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S36 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
164. RBoNT/A mutants with polypeptide extension show different kinetic properties. (25th December 2016) Authors: Jurk, Marcel; Schmidt, Michael; Scheps, Daniel; Hofmann, Fred; López de la Paz, Manuela; Frevert, Jürgen Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S46 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
165. Real-life use of onabotulinumtoxinA for the treatment of chronic migraine: 12-month repose study interim analysis. (25th December 2016) Authors: Pascual, Julio; Gaul, Charly; Davies, Brendan; Brown, Stephanie; Ahmed, Fayyaz Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
166. Real-world treatment utilization and safety of onabotulinumtoxinA for chronic migraine from an observational study in the European union. (25th December 2016) Authors: Matharu, Manjit; Pascual, Julio; Remahl, Ingela Nilsson; Straube, Andreas; Lum, Arlene; Davar, Gudarz; Odom, Dawn; Bennett, Lee; Proctor, Christina; Gutierrez, Lia; Andrews, Elizabeth; Johannes, Catherine Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S61 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
167. Recombinant botulinum neurotoxin serotype A1 (SXN102342): Protein engineering and process development. (25th December 2016) Authors: Hooker, Andy; Palan, Shilpa; Beard, Matthew Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
168. Reconstituting botulinum toxin drugs: Shaking, stirring or what?. (25th December 2016) Authors: Dressler, Dirk; Bigalke, Hans Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S23 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
169. Relationship between abobotulinumtoxina injections into shoulder muscles and patient-centered primary goal selection and achievement: Subanalyses from the upper limb international spasticity (ULIS)-II study. (25th December 2016) Authors: Jacinto, Jorge; Balcaitiene, Jovita; Maisonobe, Pascal; Fheodoroff, Klemens; Ashford, Stephen; Turner-Stokes, Lynne Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S42 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
170. Relevance and impact of including shoulder muscles in treatment of poststroke upper limb spasticity. (25th December 2016) Authors: Carvalho, Maria Pais; Pinto, Daniela; Gorayeb, Melissa; Jacinto, Jorge Journal: Toxicon Issue: Volume 123(2016) Supplement Page Start: S12 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗